lutein has been researched along with eicosapentaenoic acid in 27 studies
| Studies (lutein) | Trials (lutein) | Recent Studies (post-2010) (lutein) | Studies (eicosapentaenoic acid) | Trials (eicosapentaenoic acid) | Recent Studies (post-2010) (eicosapentaenoic acid) |
|---|---|---|---|---|---|
| 2,770 | 267 | 1,422 | 7,171 | 1,304 | 3,623 |
| Protein | Taxonomy | lutein (IC50) | eicosapentaenoic acid (IC50) |
|---|---|---|---|
| Chain A, Protein (peroxisome Proliferator Activated Receptor (ppar-delta)) | Homo sapiens (human) | 4 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 7.1 | |
| Oxoeicosanoid receptor 1 | Homo sapiens (human) | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (14.81) | 29.6817 |
| 2010's | 19 (70.37) | 24.3611 |
| 2020's | 4 (14.81) | 2.80 |
| Authors | Studies |
|---|---|
| Ghadirian, P; Nkondjock, A | 1 |
| Klasing, KC; Selvaraj, RK | 1 |
| Chiu, CJ; Gensler, G; Klein, R; Milton, RC; Taylor, A | 1 |
| Chen, F; Huangfu, J; Jiang, Y; Liu, J; Sun, Z; Wang, M; Zeng, X | 1 |
| Chew, EY; Clemons, T; Danis, R; Domalpally, A; Ferris, FL; McBee, W; SanGiovanni, JP; Sperduto, R | 1 |
| Arnold, C; Böhm, V; Dawczynski, J; Fröhlich, K; Jahreis, G; Jentsch, S; Winter, L | 1 |
| Inaba, T; Kawakita, T; Kawashima, M; Nakamura, S; Ozawa, Y; Shinmura, K; Tsubota, K; Watanabe, M | 1 |
| Cao, X; Chan, CC; Chew, EY; Ramkumar, HL; Shen, DF; Tuo, J; Zhang, J | 1 |
| Beatty, S; Meagher, KA; Nolan, JM | 1 |
| Arnold, C; Böhm, V; Jentsch, S; Schweitzer, D | 1 |
| Chen, CN; Chuang, LT; Tsai, HP | 1 |
| Gill, SS; Seitz, DP | 1 |
| Agrón, E; Bernstein, PS; Chew, EY; Clemons, TE; Grodstein, F; Launer, LJ | 1 |
| Fischer, T | 1 |
| Hammond, BR; Miller, LS; Renzi-Hammond, LM | 1 |
| Nelson, E; Salem, N; Yurko-Mauro, K | 1 |
| Bernstein, P; Chew, EY; Launer, L | 1 |
| Holzapfel, C | 1 |
| Chew, EY; Clemons, TE; Cukras, CA; Danis, RP; Domalpally, A; Friberg, TR; Sadda, SR; Toth, CA | 1 |
| Bro, T; Karlsson, M | 1 |
| Agrón, E; Chew, EY; Clemons, TE; Danis, RG; Domalpally, A; Ferris, FL; Keenan, TD; Klein, ML; Ratnapriya, R; Rosenfeld, PJ; Sadda, S; Swaroop, A; van Asten, F; Wong, WT | 1 |
| Agrón, E; Antoszyk, AN; Chew, EY; Clemons, TE; Domalpally, A; Elman, MJ; Keenan, TD; Vitale, S | 1 |
| Agrón, E; Chew, EY; Cukras, CA; Domalpally, A; Hwang, CK; Keenan, TDL; Wong, WT | 1 |
| Demmelmair, H; Goeckeler-Leopold, E; Grote, V; Holdt, L; Horak, J; Koletzko, B; Maar, K; Maggini, S; Neuhofer, C; Schaefer, E; Teupser, D; Thiel, N | 1 |
| Izumo, T; Kaneda, Y; Kondo, S; Nakai, M; Obata, H; Rogi, T; Saito, J; Sueyasu, T; Tokuda, H; Tsukiura, T; Yasumoto, K | 1 |
2 review(s) available for lutein and eicosapentaenoic acid
| Article | Year |
|---|---|
[Pharmacological therapy of age-related macular degeneration based on etiopathogenesis].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Aspirin; Bosentan; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infliximab; Lutein; Macular Degeneration; Melatonin; PPAR gamma; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Resveratrol; Stilbenes; Sulfonamides; Trimetazidine; Tumor Necrosis Factor-alpha; Ubiquinone; Vitamin D; Xanthophylls | 2015 |
[Behind blue eyes – the evidence for ocular nutritional supplements on the Swedish market].
Topics: Antioxidants; Blueberry Plants; Dietary Supplements; Docosahexaenoic Acids; Drug Therapy, Combination; Eicosapentaenoic Acid; Evidence-Based Medicine; Humans; Lutein; Macular Degeneration; Sweden; Vision Disorders; Vitamins; Zeaxanthins | 2017 |
10 trial(s) available for lutein and eicosapentaenoic acid
| Article | Year |
|---|---|
The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).
Topics: Aged; Aged, 80 and over; Dietary Supplements; Disease Progression; Docosahexaenoic Acids; Drug Therapy, Combination; Eicosapentaenoic Acid; Epidemiologic Methods; Fatty Acids, Omega-3; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Research Design; Treatment Outcome; Visual Acuity; Xanthophylls; Zeaxanthins | 2012 |
Macular xanthophylls and ω-3 long-chain polyunsaturated fatty acids in age-related macular degeneration: a randomized trial.
Topics: Aged; Aged, 80 and over; Antioxidants; Capsules; Chromans; Chromatography, High Pressure Liquid; Docosahexaenoic Acids; Double-Blind Method; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Gas Chromatography-Mass Spectrometry; Humans; Lipids; Lutein; Macular Degeneration; Male; Middle Aged; Retinal Pigments; Visual Acuity; Xanthophylls; Zeaxanthins | 2013 |
Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
Topics: Aged; beta Carotene; Dietary Supplements; Disease Progression; Docosahexaenoic Acids; Double-Blind Method; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Humans; Incidence; Lung Neoplasms; Lutein; Macular Degeneration; Male; Middle Aged; Risk; Treatment Outcome; Vitamins; Xanthophylls; Zeaxanthins; Zinc | 2013 |
Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial.
Topics: Aged; Aged, 80 and over; Algorithms; Ascorbic Acid; beta Carotene; Cognition; Copper; Dietary Supplements; Docosahexaenoic Acids; Double-Blind Method; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Hispanic or Latino; Humans; Lost to Follow-Up; Lutein; Macular Degeneration; Male; Medication Adherence; Middle Aged; Neuropsychological Tests; Outcome Assessment, Health Care; Racial Groups; Time Factors; Vitamins; Zeaxanthins; Zinc Oxide | 2015 |
Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research Grou
Topics: Aged; Aged, 80 and over; Cross-Sectional Studies; Docosahexaenoic Acids; Eicosapentaenoic Acid; Female; Fluorescein Angiography; Geographic Atrophy; Humans; Lutein; Male; Middle Aged; Optical Imaging; Prospective Studies; Retina; Retinal Drusen; Retinal Pigment Epithelium; Tomography, Optical Coherence; Wet Macular Degeneration; Zeaxanthins | 2017 |
Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.
Topics: Aged; Aged, 80 and over; Disease Progression; Docosahexaenoic Acids; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Geographic Atrophy; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Photography; Prospective Studies; Visual Acuity; Zeaxanthins | 2018 |
Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Docosahexaenoic Acids; Double-Blind Method; Drug Combinations; Eicosapentaenoic Acid; Female; Follow-Up Studies; Humans; Intravitreal Injections; Lutein; Male; Middle Aged; Prospective Studies; Surveys and Questionnaires; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration; Zeaxanthins | 2020 |
Progression of Geographic Atrophy with Subsequent Exudative Neovascular Disease in Age-Related Macular Degeneration: AREDS2 Report 24.
Topics: Aged; Aged, 80 and over; Diagnostic Imaging; Disease Progression; Docosahexaenoic Acids; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Follow-Up Studies; Geographic Atrophy; Humans; Lutein; Macula Lutea; Male; Middle Aged; Prospective Studies; Treatment Outcome; Wet Macular Degeneration; Zeaxanthins | 2021 |
Multiple Micronutrients, Lutein, and Docosahexaenoic Acid Supplementation during Lactation: A Randomized Controlled Trial.
Topics: Adult; beta Carotene; Breast Feeding; Dietary Supplements; Docosahexaenoic Acids; Double-Blind Method; Eicosapentaenoic Acid; Female; Germany; Homocysteine; Humans; Infant; Lactation; Lutein; Maternal Nutritional Physiological Phenomena; Micronutrients; Milk, Human; Vitamin B 12; Vitamin D | 2020 |
Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin on Episodic Memory in Healthy Older Adults.
Topics: Aged; Arachidonic Acid; Dietary Supplements; Docosahexaenoic Acids; Double-Blind Method; Eicosapentaenoic Acid; Fatty Acids; Fatty Acids, Omega-3; Humans; Lutein; Memory, Episodic; Zeaxanthins | 2023 |
15 other study(ies) available for lutein and eicosapentaenoic acid
| Article | Year |
|---|---|
Dietary carotenoids and risk of colon cancer: case-control study.
Topics: Adult; Aged; beta Carotene; Carotenoids; Case-Control Studies; Colonic Neoplasms; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Female; Humans; Lutein; Male; Middle Aged; Xanthophylls; Zeaxanthins | 2004 |
Lutein and eicosapentaenoic acid interact to modify iNOS mRNA levels through the PPARgamma/RXR pathway in chickens and HD11 cell lines.
Topics: Anilides; Animals; Cells, Cultured; Chickens; Drug Interactions; Eicosapentaenoic Acid; Female; Lutein; Macrophages; Male; Nitric Oxide Synthase Type II; PPAR gamma; Receptors, Cytoplasmic and Nuclear | 2006 |
AMD study: a feast for the eyes.
Topics: Aged; Aged, 80 and over; Antioxidants; beta Carotene; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Humans; Lutein; Macular Degeneration; Middle Aged; Xanthophylls; Zeaxanthins; Zinc Compounds | 2007 |
Dietary compound score and risk of age-related macular degeneration in the age-related eye disease study.
Topics: Aged; Aged, 80 and over; Ascorbic Acid; Cross-Sectional Studies; Diet; Diet Surveys; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Energy Intake; Fatty Acids, Unsaturated; Feeding Behavior; Female; Glycemic Index; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Retinal Drusen; Risk Assessment; Vitamin E; Xanthophylls; Zeaxanthins; Zinc | 2009 |
Protective actions of microalgae against endogenous and exogenous advanced glycation endproducts (AGEs) in human retinal pigment epithelial cells.
Topics: Cell Line; Cell Proliferation; Chlorella; Diabetic Retinopathy; Eicosapentaenoic Acid; Glycation End Products, Advanced; Humans; Lutein; Matrix Metalloproteinase 2; Microalgae; Plant Extracts; RNA, Messenger; Up-Regulation; Vascular Endothelial Growth Factor A; Xanthophylls | 2011 |
Calorie restriction (CR) and CR mimetics for the prevention and treatment of age-related eye disorders.
Topics: Administration, Oral; Animals; Antioxidants; Caloric Restriction; Disease Models, Animal; Eicosapentaenoic Acid; Eye Diseases; Forecasting; Humans; Lactoferrin; Lutein; Mice; Mice, Knockout; Polyphenols; Rats | 2013 |
Nutrient supplementation with n3 polyunsaturated fatty acids, lutein, and zeaxanthin decrease A2E accumulation and VEGF expression in the retinas of Ccl2/Cx3cr1-deficient mice on Crb1rd8 background.
Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Chemokine CCL2; CX3C Chemokine Receptor 1; Cyclooxygenase 2; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Gene Expression Profiling; Interleukin-1beta; Lutein; Macular Degeneration; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Electron, Transmission; Nitric Oxide Synthase Type II; Phenotype; Pyridinium Compounds; Receptors, Chemokine; Retina; Retinal Degeneration; Retinoids; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Xanthophylls; Zeaxanthins | 2013 |
Regarding macular xanthophylls and ω-3 long-chain polyunsaturated fatty acids in age-related macular degeneration.
Topics: Docosahexaenoic Acids; Eicosapentaenoic Acid; Female; Humans; Lutein; Macular Degeneration; Male; Xanthophylls | 2014 |
Regarding macular xanthophylls and ω-3 long-chain polyunsaturated fatty acids in age-related macular degeneration--reply.
Topics: Docosahexaenoic Acids; Eicosapentaenoic Acid; Female; Humans; Lutein; Macular Degeneration; Male; Xanthophylls | 2014 |
Production of long chain omega-3 fatty acids and carotenoids in tropical areas by a new heat-tolerant microalga Tetraselmis sp. DS3.
Topics: Animals; beta Carotene; Biomass; Carotenoids; Chlorophyta; Eicosapentaenoic Acid; Fatty Acids; Fatty Acids, Omega-3; Hot Temperature; Lutein; Microalgae; Tropical Climate | 2016 |
Lifestyles and Cognitive Health: What Older Individuals Can Do to Optimize Cognitive Outcomes.
Topics: Cognition; Cognitive Dysfunction; Dementia; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Executive Function; Exercise Therapy; Female; Health Promotion; Humans; Lutein; Macular Degeneration; Male; Sedentary Behavior; Vitamins; Zeaxanthins | 2015 |
Oral Nutrient Supplementation and Cognitive Function.
Topics: Cognition; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Female; Humans; Lutein; Macular Degeneration; Male; Vitamins; Zeaxanthins | 2016 |
Oral Nutrient Supplementation and Cognitive Function.
Topics: Cognition; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Female; Humans; Lutein; Macular Degeneration; Male; Vitamins; Zeaxanthins | 2016 |
Oral Nutrient Supplementation and Cognitive Function--Reply.
Topics: Cognition; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Female; Humans; Lutein; Macular Degeneration; Male; Vitamins; Zeaxanthins | 2016 |
[Supplements for cognitive function unsuitable].
Topics: Cognition; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Female; Humans; Lutein; Macular Degeneration; Male; Vitamins; Zeaxanthins | 2015 |